The famous investor advocated for investing in low-cost index funds.

Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding Pharmacies. Iran picks new leader as escalating war deepens oil shock Heavy ...

You’ve probably seen compounding making headlines recently, and not for the right reasons. From so-called “personalized” GLP-1s flooding the market to telehealth startups touting hormone “rebalancing” ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. In its latest offensive, the agency has unleashed a fresh set of 30 warning letters targeting ...

Akron, OH – The Rubber Division, ACS, upcoming trainings cover a variety of topics featured in their new March courses. March 27 – Virtual Course: Developments in Tire Materials Science & Engineering.

OpenLoop, a company providing operational and tech services to telehealth companies, and compounding pharmacy Triad Rx are being sued in a class action for selling oral tirzepatide. The complaint (PDF ...

GLP-1 weight-loss drugs are now the focus of a heated legal battle, with a leading drugmaker warning that copycat versions pose a risk to patient safety. "When you go and try to source raw materials ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

You’ve probably encountered compounded medications at some point. Maybe a pharmacy-made topical anesthetic or a customized rinse for a sensitive patient. Simply put, compounding means a pharmacist ...

A high-profile fight in the world of compounded drugs looks like it has been resolved, with telehealth firm Hims & Hers (HIMS) backing off a plan to offer a knockoff Wegovy pill for as little as $49 ...

FDA enforcement will focus on restricting GLP-1 APIs in mass-marketed, nonapproved compounded products to address unverifiable quality, safety, and efficacy under the FD&C Act. Appropriate compounding ...

Hims & Hers (HIMS) shares dropped 16% after-hours as FDA plans to restrict compounded GLP-1 ingredients and HHS referred Hims to DOJ. Hims projected $725M in weight-loss revenue for 2025 from total ...